Medicine Supply Notification: Catapres® (clonidine) 100microgram tablets – Updated

Medicine Supply Notification: Catapres® (clonidine) 100microgram tablets – Updated

October 7, 2021

Update: (07/10/2021) Resupply now expected to be w/c 11th October 2021


 

Department of Health and Social Care (DHSC) has issued a Medicine Supply Notification (MSN) for Catapres® (clonidine) 100microgram tablets

MSN/2021/037

Tier 2 – medium impact

Date of issue: 21/07/2021

  • Very limited supplies of Catapres® (clonidine) 100microgram tablets are available until w/c 4th October 2021.
  • Clonidine 25 microgram tablets remain available and able to support a full increase in demand
  • Clonidine 50 microgram /5ml oral solution sugar free remain available and able to support a full increase in demand.
  • The above preparations have different licensed indications (migraine or recurrent vascular headache and menopausal hot flushes) to Catapres® 100 microgram tablets
  • Unlicensed imports of clonidine 100 microgram tablets can be sourced. Lead times vary.

The following specialist importers have currently confirmed they can source unlicensed clonidine 100 microgram tablets (please note, there may be other companies that can also source supplies):

If there is currently no listing on dm+d for the imported product for prescribers to select using their prescribing systems an EPS prescription for unlicensed clonidine 100 microgram tablets cannot be issued. Where a prescriber wishes to prescribe an unlicensed import, an FP10 paper prescription should be issued as ‘clonidine 100 microgram tablets (Special Order)‘ and endorsed by the pharmacy as a non-Part VIIIB special with the following information:

  • Amount dispensed over pack size used;
  • Invoice price per pack size from which the order was supplied less any discount or rebate;
  • Manufacturers’/importers’ MHRA licence number;
  • Batch number of the product supplied;
  • SP

The DHSC Medicine Supply Team provide a monthly update on potential supply issues affecting both primary and secondary care. This update is uploaded on the Specialist Pharmacy Services (SPS) website. To register, you will need  an NHS email address. Once set up and logged in, you will be able to access it online.

New shortages not listed on the SPS website, can be reported using our shortage reporting tool.

 



Posted in: ,


More Latest News >

PQS: AMS virtual event now on-demand

Community pharmacy contractors can now access an online recording of the antimicrobial stewardship (AMS) virtual event, which was jointly hosted...

Evaluation of LFD tests

As part of meeting Medicines and Healthcare products Regulatory Agency (MHRA) obligations, the UK Health Security Agency (UKHSA) – of...